KS

Kesavan Suseela Devi

Active Director Director DIN 10446257
DIN 10446257 First appointment Dec 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2023
Shareholding value •••• Premium profile

About Kesavan Suseela Devi

Data last updated:

Kesavan Suseela Devi is a Director at Lilac Diagnostics Private Limited (since 2023). Lilac Diagnostics Private Limited reported revenue of ₹1.56 Cr (FY 2025).

DIN 10446257
Primary Designation Director
First Appointment 29 Dec 2023
Oldest Company Age 2 yrs
Largest company Lilac Diagnostics Private Limited · ₹1.56 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lilac Diagnostics Private Limited U86905KL2023PTC085385
Director29 Dec 20232023₹1.56 Cr (FY 2025)Active

Board colleagues of Kesavan Suseela Devi

Directorship timeline

Open interactive timeline →
Lilac Diagnostics Private Limited
Premium access

Shareholding and investment profile for Kesavan Suseela Devi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kesavan Suseela Devi

Kesavan Suseela Devi currently holds 1 directorship: Lilac Diagnostics Private Limited (Director, since 29 Dec 2023, revenue ₹1.56 Cr (FY 2025)).

Kesavan Suseela Devi was first appointed on 29 Dec 2023 as Director at Lilac Diagnostics Private Limited.

The current boards of Kesavan Suseela Devi's companies include Sabine Sivadasan (Lilac Diagnostics Private Limited), Smitha Kunjan Lexman (Lilac Diagnostics Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available